Mrs Renee Holmes
Chair, Mitrofanoff Support
About this event
- Date and time Fri 14 Oct 2022 from 8:30am to 4:40pm
- Location Royal Society of Medicine
- Organised by Urology
Attend this event to examine the journey of cancer patients, through treatment and into survivorship, by hearing from both patients and medical professionals.
Leading experts will lecture on management strategies for urological side effects that may result from cancer treatment and complications, such as sexual dysfunction, chronic pain and urinary problems.
We will also take time to consider the psychology of survivorship and how the medical profession can help patients navigate this journey.
Aims of this lecture include:
- To understand the impact of cancer and its treatment on patients.
- To understand the concept of survivorship.
- To recognize the symptoms and complications of cancer and its treatment.
- To improve understanding on how complications can be managed.
Book to attend this event in person or virtually. To view the rates and agenda, please select your preference below.
Follow us on:
Show Virtual / In Person rates
Key speakers
Dr Sarah Psutka
Associate Professor of Urology, University of Washington
Speaker's biography
Dr Sarah Psutka MD, MSc is an Associate Professor of Urology in the Department of Urology at the University of Washington and Fred Hutchinson Cancer Center. She received her undergraduate and medical degrees from Harvard University and completed urology residency training at the Massachusetts General Hospital. She completed a Society of Urologic Oncology Fellowship in Urologic Oncology at the Mayo Clinic, and concurrently obtained her Masters’ in Clinical and Translational Science.
Dr Psutka’s clinical efforts focus on minimally-invasive and complex open urologic oncology, with a particular interest in advanced bladder, kidney, and testis cancer. She leads the urologic oncology program at Harborview Medical Center and is the Associate Program Director of the UW Society of Urologic Oncology Fellowship Program.
Dr Psutka’s research focuses on the study and development of personalized, comprehensive risk stratification measures in patients with advanced urologic malignancies. She leads research studying the integration of principles of aging research, comprehensive geriatric assessments, body composition, and psychometric capital assessments in patients with advanced genitourinary malignancies with a focus on patient-reported outcomes and development of prehabilitation interventions. She currently leads multiple clinical trials in bladder and kidney cancer. Her research has been funded by the Bladder Cancer Advocacy Network and she was the 2022 Recipient of the Society of Urologic Oncology Young Investigator Award. She is a member of the Board of Directors of the Society of Urologic Oncology, the Society of Urologic Oncology Clinical Trials Consortium (Kidney), The Society of Urologic Oncology Fellowship Committee and Education Committee, the SWOG Clinical Trials Survivorship Committee, and the Bladder Cancer Advocacy Network Steering Committee. She was a co-founder of the Society of Women in Urologic Oncology.
Dr Psutka is the Senior Editor for the Urologic Oncology Section of the American Urological Association Core Curriculum and is an Associate Editor for European Urology.
Dr Clare Allen
Consultant Radiologist, University College London Hospitals NHS Trust
Professor Maarten Albersen
Professor of Urology, University Hospitals Leuven
Agenda
View the programme (In person)
Registration, tea and coffee
Morning session
Welcome and introduction
Ms Nadine Coull, President, Urology Section, Royal Society of Medicine
But you’re cured, so you’re fine
Mrs Renee Holmes, Chair, Mitrofanoff Support
What is survivorship?
Mr Derek Rosario, Urologist, Sheffield Teaching Hospitals NHS Foundation Trust
The psychology of survivorship
Dr Sahil Suleman, Macmillan Consultant Clinical Psychologist, St George's University Hospitals NHS Foundation Trust
Sexual dysfunction following treatment for cancer
Miss Lorraine Grover, Psychosexual Nurse Specialist, The Prostate Centre
Questions and answers
Tea and coffee break
Tools for measurement in in survivorship
Dr Sarah Psutka, Associate Professor of Urology, University of Washington
Management of chronic pain following treatment for Cancer
Dr Richard Gordon-Williams, Consultant in Anaesthesia and Pain Medicine, The Royal Marsden Hospital
Long-term complications of radiotherapy for urological cancers
Mr Arun Sahai, Consultant Urological Surgeon, Guy's and St Thomas' NHS Foundation Trust
Questions and answers
Lunch
Afternoon Session: When things go wrong
Imaging the problem
Dr Clare Allen, Consultant Radiologist, University College London Hospitals NHS Trust
Post treatment fistulae - a ticking time bomb
Miss Tamsin Greenwell, Consultant Urological Surgeon, University College London Hospitals and Honorary Associate Professor, University College London
Post treatment strictures
Professor Anthony Mundy, Professor of Urology and Consultant Urological Surgeon, University College London Hospitals
Post treatment urinary symptoms
Mr Mark Speakman, Consultant Urologist, Taunton and Somerset NHS Foundation Trust
Post treatment erectile dysfunction
Professor Maarten Albersen, Professor of Urology, University Hospitals Leuven
Questions and answers
State of the art lecture: Current Management of penile cancer
Professor Maarten Albersen
Closing remarks
Ms Nadine Coull
Close of meeting
View the programme (Virtual)
Morning session
Welcome and introduction
Ms Nadine Coull, President, Urology Section, Royal Society of Medicine
But you’re cured, so you’re fine
Mrs Renee Holmes, Chair, Mitrofanoff Support
What is survivorship?
Mr Derek Rosario, Urologist, Sheffield Teaching Hospitals NHS Foundation Trust
The psychology of survivorship
Dr Sahil Suleman, Macmillan Consultant Clinical Psychologist, St George's University Hospitals NHS Foundation Trust
Sexual dysfunction following treatment for cancer
Miss Lorraine Grover, Psychosexual Nurse Specialist, The Prostate Centre
Questions and answers
Comfort break
Tools for measurement in in survivorship
Dr Sarah Psutka, Associate Professor of Urology, University of Washington
Management of chronic pain following treatment for Cancer
Dr Richard Gordon-Williams, Consultant in Anaesthesia and Pain Medicine, The Royal Marsden Hospital
Long-term complications of radiotherapy for urological cancers
Mr Arun Sahai, Consultant Urological Surgeon, Guy's and St Thomas' NHS Foundation Trust
Questions and answers
Comfort break
Afternoon session: When things go wrong
Imaging the problem
Dr Clare Allen, Consultant Radiologist, University College London Hospitals NHS Trust
Post treatment fistulae - a ticking time bomb
Miss Tamsin Greenwell, Consultant Urological Surgeon, University College London Hospitals and Honorary Associate Professor, University College London
Post treatment strictures
Professor Anthony Mundy, Professor of Urology and Consultant Urological Surgeon, University College London Hospitals
Post treatment urinary symptoms
Mr Mark Speakman, Consultant Urologist, Taunton and Somerset NHS Foundation Trust
Post treatment erectile dysfunction
Professor Maarten Albersen, Professor of Urology, University Hospitals Leuven
Questions and answers
State of the art lecture: Current Management of penile cancer
Professor Maarten Albersen
Closing remarks
Ms Nadine Coull
Close of meeting
Location
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Registration for this event will close at 1:00am on 13 October 2022. Late registrations will not be accepted.
The agenda is subject to change at any time
If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM discretion.
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.